LONDON, May 2, 2001 (LSN.ca) – The Society for the Protection of Unborn Children (SPUC), Britain’s longest established pro-life group, has been granted leave by the High Court in London for a legal challenge to sales of the abortifacient morning-after pill from pharmacists. On Wednesday, the High Court granted permission to bring a judicial review of the reclassification of the Levonelle-2 morning-after pill as a drug available to women over 16 from pharmacists without a doctor’s prescription.
John Smeaton, SPUC’s national director, was pleased with the decision to allow a hearing. He said, “this is a major public policy issue affecting the health of women in this country and in particular young women – which coincidentally is a case of the government seeking to circumvent the Abortion Act. Here we have pharmacists having the burden imposed on them of providing abortion by the morning-after pill in a totally unsupervised way, and no-one knows the impact of this drug on women.”
For more see the SPUC release and the BBC coverage at: https://www.spuc.org.uk/releases/20010502.htm https://news.bbc.co.uk/hi/english/health/newsid_1308000/1308528.stm